CHA Biotech Co. Ltd - Asset Resilience Ratio

Latest as of December 2025: 3.99%

CHA Biotech Co. Ltd (085660) has an Asset Resilience Ratio of 3.99% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read CHA Biotech Co. Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩101.67 Billion

≈ $68.90 Million USD Cash + Short-term Investments

Total Assets

₩2.55 Trillion

≈ $1.73 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2008–2025)

This chart shows how CHA Biotech Co. Ltd's Asset Resilience Ratio has changed over time. See 085660 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down CHA Biotech Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 085660 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩101.67 Billion	3.99%
Total Liquid Assets	₩101.67 Billion	3.99%

Asset Resilience Insights

Limited Liquidity: CHA Biotech Co. Ltd maintains only 3.99% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

CHA Biotech Co. Ltd Industry Peers by Asset Resilience Ratio

Compare CHA Biotech Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for CHA Biotech Co. Ltd (2008–2025)

The table below shows the annual Asset Resilience Ratio data for CHA Biotech Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	3.99%	₩101.67 Billion ≈ $68.90 Million	₩2.55 Trillion ≈ $1.73 Billion	-0.75pp
2024-12-31	4.74%	₩104.10 Billion ≈ $70.55 Million	₩2.19 Trillion ≈ $1.49 Billion	-4.59pp
2023-12-31	9.34%	₩161.09 Billion ≈ $109.17 Million	₩1.73 Trillion ≈ $1.17 Billion	-5.49pp
2022-12-31	14.83%	₩238.32 Billion ≈ $161.51 Million	₩1.61 Trillion ≈ $1.09 Billion	-6.59pp
2021-12-31	21.43%	₩328.90 Billion ≈ $222.89 Million	₩1.54 Trillion ≈ $1.04 Billion	-4.75pp
2020-12-31	26.17%	₩343.83 Billion ≈ $233.01 Million	₩1.31 Trillion ≈ $890.28 Million	+0.99pp
2019-12-31	25.18%	₩292.86 Billion ≈ $198.47 Million	₩1.16 Trillion ≈ $788.10 Million	-0.10pp
2018-12-31	25.29%	₩239.59 Billion ≈ $162.36 Million	₩947.53 Billion ≈ $642.13 Million	-9.23pp
2017-12-31	34.52%	₩273.95 Billion ≈ $185.65 Million	₩793.61 Billion ≈ $537.82 Million	-7.57pp
2016-12-31	42.09%	₩323.62 Billion ≈ $219.31 Million	₩768.93 Billion ≈ $521.09 Million	+26.34pp
2015-12-31	15.75%	₩101.53 Billion ≈ $68.80 Million	₩644.83 Billion ≈ $436.99 Million	+2.24pp
2014-12-31	13.50%	₩83.85 Billion ≈ $56.82 Million	₩620.88 Billion ≈ $420.76 Million	-13.12pp
2013-12-31	26.63%	₩182.51 Billion ≈ $123.68 Million	₩685.47 Billion ≈ $464.53 Million	+6.88pp
2012-12-31	19.75%	₩102.39 Billion ≈ $69.39 Million	₩518.47 Billion ≈ $351.36 Million	-2.98pp
2011-12-31	22.73%	₩107.96 Billion ≈ $73.16 Million	₩475.02 Billion ≈ $321.91 Million	+18.93pp
2010-12-31	3.80%	₩12.70 Billion ≈ $8.60 Million	₩334.30 Billion ≈ $226.55 Million	-1.74pp
2009-12-31	5.54%	₩12.65 Billion ≈ $8.57 Million	₩228.35 Billion ≈ $154.75 Million	-24.92pp
2008-12-31	30.45%	₩31.64 Billion ≈ $21.44 Million	₩103.88 Billion ≈ $70.40 Million	--

pp = percentage points

About CHA Biotech Co. Ltd

KQ:085660 Korea Biotechnology

Market Cap

$885.14 Million

₩1.31 Trillion KRW

Market Cap Rank

#9659 Global

#275 in Korea

Share Price

₩17090.00

Change (1 day)

-1.78%

52-Week Range

₩9870.00 - ₩23850.00

All Time High

₩40950.00